Seroprevalence surveys in sub-Saharan Africa: what do they tell us?
Open accessAbstract
Initial estimates of the potential effect of SARS-CoV-2 virus in sub-Saharan Africa were catastrophic:1 fortunately, these predictions have not been met in terms of number of cases, deaths, and saturation of health systems. On one hand, since ageing is the main risk factor for COVID-19,2 the young population in sub-Saharan Africa partly explains the low number of cases and deaths registered. On the other hand, the limited testing capacity in many sub-Saharan Africa countries, accompanied by stigmatisation, might result in underestimation of the magnitude of transmission.
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Cites
Seroprevalence of anti–SARS-CoV-2 IgG antibodies in Kenyan blood donors
Uyoga, S., Adetifa, I. M. O., Karanja, H. K., Nyagwange, J., Tuju, J., Wanjiku, P., Aman, R., Mwangangi, M., Amoth, P., Kasera, K., et al. (2021) · Science · doi:10.1126/science.abe1916 · Cited by 328 · see citing works
Mulenga, L. B., Hines, J. Z., Fwoloshi, S., Chirwa, L., Siwingwa, M., Yingst, S., Wolkon, A., Barradas, D. T., Favaloro, J., Zulu, J. E., et al. (2021) · The Lancet Global Health · doi:10.1016/s2214-109x(21)00053-x · Cited by 149 · see citing works
Chibwana, M. G., Jere, K. C., Kamng'ona, R., Mandolo, J., Katunga-Phiri, V., Tembo, D., Mitole, N., Musasa, S., Sichone, S., Lakudzala, A., et al. (2020) · Wellcome Open Research · doi:10.12688/wellcomeopenres.16188.1 · Cited by 110 · see citing works
Flagged first, then by citations
Research works printed but not linked: 6
- 1 Massinga Loembe M, Tshangela A, Salyer SJ, Varma JK, Ouma AEO, Nkengasong JN. COVID-19 in Africa: the spread and response. Nat Med 2020; 26: 999-1003.
- 2 de Lusignan S, Dorward J, Correa A, et al. Risk factors for SARS-CoV-2 among patients in the Oxford Royal College of General Practitioners Research and Surveillance Centre primary care network: a cross-sectional study. Lancet Infect Dis 2020; 20: 1034-42.
- 5 Olayanju O, Bamidele O, Edem F, et al. SARS-CoV-2 seropositivity in asymptomatic frontline health workers in Ibadan, Nigeria. Am J Trop Med Hyg 2021; 104: 91-94.
- 7 Mendelson M, Madhi S. South Africa's coronavirus testing strategy is broken and not fit for purpose: it's time for a change. S Afr Med J 2020; 110: 429-31.
- 8 Sadio AJ, Gbeasor-Komlanvi FA, Konu RY, et al. Assessment of selfmedication practices in the context of the COVID-19 outbreak in Togo. BMC Public Health 2021; 21: 58.
- 9 Long QX, Tang XJ, Shi QL, et al. Clinical and immunological assessment of asymptomatic SARS-CoV-2 infections. Nat Med 2020; 26: 1200-04.
Cited by
Sorted by citations
The Lancet Commission on lessons for the future from the COVID-19 pandemic
Sachs, J. D., Karim, S. S. A., Aknin, L., Allen, J., Brosbøl, K., Colombo, F., Barron, G. C., Espinosa, M. F., Gaspar, V., Gaviria, A., et al. (2022) · The Lancet · doi:10.1016/s0140-6736(22)01585-9 · Cited by 842 · see citing works
- Authors
- Usuf, E., & Roca, A.
- Affiliations
- MRC Unit the Gambia (GM)
- Corresponding author
- Usuf, Effua
- Venue
- The Lancet Global Health
- Publisher
- Elsevier BV
- Published
- 2021-06
- Volume
- 9
- Issue
- 6
- Pages
- e724-e725
- ISSN
- 2214-109X (ISSN-L)
- OpenAlex
- W3134769325
- Cited by
- 43
- References
- 3
- Citations by year
- 2026: 1 · 2025: 2 · 2024: 6 · 2023: 9 · 2022: 13 · 2021: 12
- FWCI
- 3.88
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- The Lancet Global Health (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- LSHTM Research Online (London School of Hygiene and Tropical Medicine) (acceptedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- Medical Research Council (MC_PC_20028)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 detection and testing
- Keywords
- SARS-CoV-2, COVID-19 pandemic, seroprevalence, sub-Saharan Africa, testing capacity, stigma, youth population, health system capacity, risk factors
- MeSH terms
- Humans, Surveys and Questionnaires, Seroepidemiologic Studies, Africa South of the Sahara
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
